Pub Date : 2023-06-24DOI: 10.1097/JDN.0000000000000745
Yen Nguyen, Nancy G Russell
ABSTRACT Cutaneous manifestations of human immunodeficiency virus (HIV) are commonly seen in clinical practice. Almost every person living with HIV (PLWH) will present with a dermatological complaint at some point during their care. Compared with people living without HIV, PLWHs have a greater likelihood of skin eruptions because of dysregulation of the skin immune system or drug reactions. This article reviews the most common dermatological conditions in PLWHs, as well as how they typically present in clinical practice, and discusses current evidence for treatment.
{"title":"Cutaneous Manifestations of Sexually Transmitted Infections","authors":"Yen Nguyen, Nancy G Russell","doi":"10.1097/JDN.0000000000000745","DOIUrl":"https://doi.org/10.1097/JDN.0000000000000745","url":null,"abstract":"ABSTRACT Cutaneous manifestations of human immunodeficiency virus (HIV) are commonly seen in clinical practice. Almost every person living with HIV (PLWH) will present with a dermatological complaint at some point during their care. Compared with people living without HIV, PLWHs have a greater likelihood of skin eruptions because of dysregulation of the skin immune system or drug reactions. This article reviews the most common dermatological conditions in PLWHs, as well as how they typically present in clinical practice, and discusses current evidence for treatment.","PeriodicalId":17315,"journal":{"name":"Journal of the Dermatology Nurses' Association","volume":"31 1","pages":"181 - 189"},"PeriodicalIF":0.4,"publicationDate":"2023-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80653759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-24DOI: 10.1097/jdn.0000000000000751
{"title":"Cutaneous Manifestations of Sexually Transmitted Infections: HIV","authors":"","doi":"10.1097/jdn.0000000000000751","DOIUrl":"https://doi.org/10.1097/jdn.0000000000000751","url":null,"abstract":"","PeriodicalId":17315,"journal":{"name":"Journal of the Dermatology Nurses' Association","volume":"1 1","pages":""},"PeriodicalIF":0.4,"publicationDate":"2023-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74797448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-24DOI: 10.1097/jdn.0000000000000733
Diana Ashouri, S. Jacob
Teledermatology is a term to describe the provision of dermatologic medical services through telecommunication technology. This is a case of a large axillary papule in a patient with metabolic syndrome.
远程皮肤病学是一个描述通过电信技术提供皮肤医学服务的术语。这是一例代谢综合征患者腋窝大丘疹。
{"title":"Large Pedunculated Papule on the Left Axilla","authors":"Diana Ashouri, S. Jacob","doi":"10.1097/jdn.0000000000000733","DOIUrl":"https://doi.org/10.1097/jdn.0000000000000733","url":null,"abstract":"\u0000 Teledermatology is a term to describe the provision of dermatologic medical services through telecommunication technology. This is a case of a large axillary papule in a patient with metabolic syndrome.","PeriodicalId":17315,"journal":{"name":"Journal of the Dermatology Nurses' Association","volume":"1 1","pages":""},"PeriodicalIF":0.4,"publicationDate":"2023-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88480247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-24DOI: 10.1097/jdn.0000000000000749
Sujitha Yadlapati, Faraz Yousefian, Leah Shama-Brown, Valeria J. González-Molina
Sister Mary Joseph's nodules are commonly associated with internal malignancies. It usually manifests as a nodule with an irregular border around umbilicus, however, it may present as blue–black, friable, ulcerated lump with drainage as large as 10 cm. Sister Mary Joseph's nodules has a poor prognosis with average survival time of 11 months. We report an 85-year-old female presenting with painless, erythematous nodules on the umbilicus that developed over one month. Histopathology findings of skin biopsy was consistent with metastatic adenocarcinoma. Computerized tomography imaging of abdomen and pelvic showed a large pelvic mass obstructing the sigmoid colon. The patient was subsequently managed by a multidisciplinary surgical and medical oncology team.
{"title":"Sister Mary Joseph's Nodules","authors":"Sujitha Yadlapati, Faraz Yousefian, Leah Shama-Brown, Valeria J. González-Molina","doi":"10.1097/jdn.0000000000000749","DOIUrl":"https://doi.org/10.1097/jdn.0000000000000749","url":null,"abstract":"\u0000 Sister Mary Joseph's nodules are commonly associated with internal malignancies. It usually manifests as a nodule with an irregular border around umbilicus, however, it may present as blue–black, friable, ulcerated lump with drainage as large as 10 cm. Sister Mary Joseph's nodules has a poor prognosis with average survival time of 11 months. We report an 85-year-old female presenting with painless, erythematous nodules on the umbilicus that developed over one month. Histopathology findings of skin biopsy was consistent with metastatic adenocarcinoma. Computerized tomography imaging of abdomen and pelvic showed a large pelvic mass obstructing the sigmoid colon. The patient was subsequently managed by a multidisciplinary surgical and medical oncology team.","PeriodicalId":17315,"journal":{"name":"Journal of the Dermatology Nurses' Association","volume":"50 1","pages":""},"PeriodicalIF":0.4,"publicationDate":"2023-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86081371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-23DOI: 10.1097/jdn.0000000000000746
J. Baumann, Andrew Groneck, Kari Martin
Dermatofibrosarcoma protuberans is a soft tissue tumor that arises from the dermis. This relatively rare, low-grade tumor has a high propensity for local recurrence unless it is completely excised. Dermatofibrosarcoma protuberans classically progresses slowly as a plaque on the trunk of young adults. It often resembles a scar that is slowly growing over months to years. Because of its rarity and subtle progression, this form of skin cancer will often go undiagnosed for years. Over time, dermatofibrosarcoma protuberans can become invasive into the subcutaneous fat, muscle, fascia, and chest wall. Diagnosis of dermatofibrosarcoma protuberans is made by a core needle or incisional biopsy. Once diagnosed, cure rates approach 100%. The purpose of this article is to review the epidemiology, pathophysiology, clinical features, differential diagnosis, diagnosis, staging, and treatment of dermatofibrosarcoma protuberans. Increasing healthcare providers' awareness about this rare form of skin cancer and its recognition may improve patient outcomes.
{"title":"Skin Cancer: Back to Basics","authors":"J. Baumann, Andrew Groneck, Kari Martin","doi":"10.1097/jdn.0000000000000746","DOIUrl":"https://doi.org/10.1097/jdn.0000000000000746","url":null,"abstract":"\u0000 Dermatofibrosarcoma protuberans is a soft tissue tumor that arises from the dermis. This relatively rare, low-grade tumor has a high propensity for local recurrence unless it is completely excised. Dermatofibrosarcoma protuberans classically progresses slowly as a plaque on the trunk of young adults. It often resembles a scar that is slowly growing over months to years. Because of its rarity and subtle progression, this form of skin cancer will often go undiagnosed for years. Over time, dermatofibrosarcoma protuberans can become invasive into the subcutaneous fat, muscle, fascia, and chest wall. Diagnosis of dermatofibrosarcoma protuberans is made by a core needle or incisional biopsy. Once diagnosed, cure rates approach 100%. The purpose of this article is to review the epidemiology, pathophysiology, clinical features, differential diagnosis, diagnosis, staging, and treatment of dermatofibrosarcoma protuberans. Increasing healthcare providers' awareness about this rare form of skin cancer and its recognition may improve patient outcomes.","PeriodicalId":17315,"journal":{"name":"Journal of the Dermatology Nurses' Association","volume":"11 1","pages":""},"PeriodicalIF":0.4,"publicationDate":"2023-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72674433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-14DOI: 10.1097/jdn.0000000000000747
Tonja Johnson, Sylvana A. Brickley
The Beautifully Unblemished Vitiligo Support Group is based in Florida, United States. In this article, Tonja Johnson, the founder of the Beautifully Unblemished Vitiligo Support Group, talks about her experience with having vitiligo and offers her perspective on how nurses can provide excellent care to patients with vitiligo.
{"title":"Patient Perspective Column","authors":"Tonja Johnson, Sylvana A. Brickley","doi":"10.1097/jdn.0000000000000747","DOIUrl":"https://doi.org/10.1097/jdn.0000000000000747","url":null,"abstract":"\u0000 The Beautifully Unblemished Vitiligo Support Group is based in Florida, United States. In this article, Tonja Johnson, the founder of the Beautifully Unblemished Vitiligo Support Group, talks about her experience with having vitiligo and offers her perspective on how nurses can provide excellent care to patients with vitiligo.","PeriodicalId":17315,"journal":{"name":"Journal of the Dermatology Nurses' Association","volume":"47 1","pages":""},"PeriodicalIF":0.4,"publicationDate":"2023-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77724122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-05-01DOI: 10.1097/jdn.0000000000000739
Faraz Yousefian, Liliana Espinoza, McKay Frandsen, Sujitha Yadlapati, A. Eckert, J. Bandino
{"title":"A Case of Subcutaneous Sarcoidosis Treated With Intralesional Kenalog","authors":"Faraz Yousefian, Liliana Espinoza, McKay Frandsen, Sujitha Yadlapati, A. Eckert, J. Bandino","doi":"10.1097/jdn.0000000000000739","DOIUrl":"https://doi.org/10.1097/jdn.0000000000000739","url":null,"abstract":"","PeriodicalId":17315,"journal":{"name":"Journal of the Dermatology Nurses' Association","volume":"4 1","pages":""},"PeriodicalIF":0.4,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82430511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-05-01DOI: 10.1097/jdn.0000000000000742
Kyleen E. Davis
By now, dermatology nurses should be exceedingly aware of the dangers of indoor tanning. Over 10 years ago, the World Health Organization and the U.S. Department of Health and Human Services proclaimed artificial tanning through tanning beds and sun lamps to be carcinogenic (American Academy of Dermatology, 2022a). In 2014, after multiple proposed bans on indoor tanning, The U.S. Food and Drug Administration (FDA) required a black box warning to be placed on all indoor tanning products restricting access to minors (FDA, 2019). Numerous studies have shown a strong link between indoor tanning and premature skin aging, skin cancers, and ocular melanoma (FDA, 2015). Specifically, studies showed that with any reported history of indoor tanning use, the risk of basal and squamous cell carcinomas increased by 24% and 58%, respectively (American Academy of Dermatology, 2022a). In individuals who first used a tanning bed before the age of 35 years, the risk of melanoma—the deadliest form of skin cancer—increased by a startling 75% (Chien & Jacob, 2022). In fact, indoor tanning has led to more cases of skin cancer worldwide than smoking has to lung cancer (Chien & Jacob, 2022; Figure 1).FIGURE 1.: Squamous cell carcinoma on the posterior leg. Photo courtesy of Maral Skelsey, MD, Dermatologic Surgery Center of Washington. Used with permission.Despite the overwhelming evidence of its risks, approximately 7.8 million adults in the United States continued to participate in indoor tanning activities as of 2015 (Guy et al., 2017). Surveys on the global prevalence of indoor tanning between 2013 and 2018 revealed utilization rates of 6.5% for adolescents and 10.4% for adults (American Academy of Dermatology, 2022a). Although these numbers have been declining over time, indoor tanning remains a significant public health threat (Figure 2).FIGURE 2.: Image of an indoor tanning bed. Photo credit: pixel2008.In individuals who desire a sun-tanned appearance, the application of artificial tanning products containing dihydroxyacetone (DHA) may provide a safer alternative to indoor tanning (Misitzis & Weinstock, 2019). DHA is FDA approved for topical skin application but “should not be inhaled, ingested, or exposed to areas covered by mucous membranes” (FDA, 2022). With topical application, DHA triggers the formation of brown pigment in the top layer of skin. This short-term tanned skin effect is eventually removed by the normal skin sloughing process (Wickett, 2005). The increasing availability and use of sunless tanning products prompts questions about their efficacy as a skin cancer risk reduction measure. In this issue of the Journal of the Dermatology Nurses' Association (JDNA), authors Andrew Seidenberg, PhD, MPH, Anne K. Julian, PhD, MA, Anne M. Hartman, MS, MA, and Dawn Holman, MPH, analyzed data from the 2015 National Health Interview Survey to “determine the prevalence and risk factors associated with sunless and indoor tanning use among non-Hispanic white women,
例如，在支持使用无太阳晒黑产品的患者中，应评估同时使用室内晒黑的情况，并应提醒患者，无太阳晒黑产品不能提供足够的保护，防止晒伤或烧伤(Holman等人，2018)。护士还必须意识到许多人想要晒黑皮肤的文化压力，并努力采取公共卫生措施，帮助改变社会规范。随着皮肤癌的诊断和治疗给医疗保健系统带来了巨大的压力，发病率不断上升，皮肤科护士熟练地检测和管理这些癌症将变得越来越重要。研究表明，大约五分之一的美国人在他们的一生中会患上皮肤癌，目前美国有超过一百万人患有黑色素瘤(美国皮肤病学会，2022b)。1982年至2011年间，黑色素瘤发病率翻了一番，并且在老年人中继续上升(美国皮肤病学会，2022b)。然而，研究表明，护理和医学生在防晒行为方面的知识存在差距(Haney et al.， 2018;Ivanov et al.， 2018)。将适当的皮肤癌和防晒培训纳入健康科学课程的未来措施是必不可少的(图3)。额头上的恶性黑色素瘤。图片由华盛顿皮肤外科中心的医学博士Maral Skelsey提供。经允许使用。为了帮助皮肤科护士早期发现和管理皮肤癌，JDNA开始在2020年初推出的“回归基础，皮肤癌专栏”中对各种皮肤癌进行简化审查。从那时起，来自护理和医疗界的有才华的作者贡献了深思熟虑的和写得很好的文章，涵盖了诸如鳞状细胞癌、无色素黑色素瘤、默克尔细胞癌、基底细胞癌、光化性角化病、肛门生殖器鳞状细胞癌和皮肤纤维肉瘤隆突等主题。我们希望读者发现这些文章是有益的，并有助于扩大他们的皮肤癌的检测和管理的知识。来自“皮肤癌专栏”的文章以及Seidenberg等人(2023)的前沿研究表明，JDNA努力为皮肤科护士提供最佳护理患者所需的材料。说到继续教育，每年的这个时候回顾防晒行为的文献尤为重要。本期《JDNA》策略性地刊登了一些关于室内晒黑和皮肤癌的专题，以介于“黑色素瘤星期一”和“不要油炸日”之间，这是一个提高人们对需要采取公共卫生措施预防晒伤和皮肤癌的认识的时刻。通过不断努力提高对皮肤癌和防晒行为的了解，护士可以帮助减少皮肤癌对患者和社区的影响。凯琳·e·戴维斯皮肤科外科中心，华盛顿，切维蔡斯，马里兰州
{"title":"The Dangers of Indoor Tanning","authors":"Kyleen E. Davis","doi":"10.1097/jdn.0000000000000742","DOIUrl":"https://doi.org/10.1097/jdn.0000000000000742","url":null,"abstract":"By now, dermatology nurses should be exceedingly aware of the dangers of indoor tanning. Over 10 years ago, the World Health Organization and the U.S. Department of Health and Human Services proclaimed artificial tanning through tanning beds and sun lamps to be carcinogenic (American Academy of Dermatology, 2022a). In 2014, after multiple proposed bans on indoor tanning, The U.S. Food and Drug Administration (FDA) required a black box warning to be placed on all indoor tanning products restricting access to minors (FDA, 2019). Numerous studies have shown a strong link between indoor tanning and premature skin aging, skin cancers, and ocular melanoma (FDA, 2015). Specifically, studies showed that with any reported history of indoor tanning use, the risk of basal and squamous cell carcinomas increased by 24% and 58%, respectively (American Academy of Dermatology, 2022a). In individuals who first used a tanning bed before the age of 35 years, the risk of melanoma—the deadliest form of skin cancer—increased by a startling 75% (Chien & Jacob, 2022). In fact, indoor tanning has led to more cases of skin cancer worldwide than smoking has to lung cancer (Chien & Jacob, 2022; Figure 1).FIGURE 1.: Squamous cell carcinoma on the posterior leg. Photo courtesy of Maral Skelsey, MD, Dermatologic Surgery Center of Washington. Used with permission.Despite the overwhelming evidence of its risks, approximately 7.8 million adults in the United States continued to participate in indoor tanning activities as of 2015 (Guy et al., 2017). Surveys on the global prevalence of indoor tanning between 2013 and 2018 revealed utilization rates of 6.5% for adolescents and 10.4% for adults (American Academy of Dermatology, 2022a). Although these numbers have been declining over time, indoor tanning remains a significant public health threat (Figure 2).FIGURE 2.: Image of an indoor tanning bed. Photo credit: pixel2008.In individuals who desire a sun-tanned appearance, the application of artificial tanning products containing dihydroxyacetone (DHA) may provide a safer alternative to indoor tanning (Misitzis & Weinstock, 2019). DHA is FDA approved for topical skin application but “should not be inhaled, ingested, or exposed to areas covered by mucous membranes” (FDA, 2022). With topical application, DHA triggers the formation of brown pigment in the top layer of skin. This short-term tanned skin effect is eventually removed by the normal skin sloughing process (Wickett, 2005). The increasing availability and use of sunless tanning products prompts questions about their efficacy as a skin cancer risk reduction measure. In this issue of the Journal of the Dermatology Nurses' Association (JDNA), authors Andrew Seidenberg, PhD, MPH, Anne K. Julian, PhD, MA, Anne M. Hartman, MS, MA, and Dawn Holman, MPH, analyzed data from the 2015 National Health Interview Survey to “determine the prevalence and risk factors associated with sunless and indoor tanning use among non-Hispanic white women,","PeriodicalId":17315,"journal":{"name":"Journal of the Dermatology Nurses' Association","volume":"191 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135050917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-05-01DOI: 10.1097/01.nurse.0000298222.30791.65
Kyleen E. Davis
{"title":"The Dangers of Indoor Tanning","authors":"Kyleen E. Davis","doi":"10.1097/01.nurse.0000298222.30791.65","DOIUrl":"https://doi.org/10.1097/01.nurse.0000298222.30791.65","url":null,"abstract":"","PeriodicalId":17315,"journal":{"name":"Journal of the Dermatology Nurses' Association","volume":"5 1","pages":""},"PeriodicalIF":0.4,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84769476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-05-01DOI: 10.1097/jdn.0000000000000741
Angela L. Borger
{"title":"Reconnecting","authors":"Angela L. Borger","doi":"10.1097/jdn.0000000000000741","DOIUrl":"https://doi.org/10.1097/jdn.0000000000000741","url":null,"abstract":"","PeriodicalId":17315,"journal":{"name":"Journal of the Dermatology Nurses' Association","volume":"53 1","pages":""},"PeriodicalIF":0.4,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88612992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：